# Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes

> **NCT02408120** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 226 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin glargine
- **DRUG:** Insulin aspart
- **DRUG:** Supplemental insulin aspart

## Key facts

- **NCT ID:** NCT02408120
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2019-12-11
- **Final completion:** 2019-12-11
- **Target enrollment:** 226 (ACTUAL)
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02408120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02408120, "Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02408120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*